Home/Publication/BGH to Acquire JSE-listed Aspen Pharmacare’s APAC Operations
BGH to Acquire JSE-listed Aspen Pharmacare’s APAC Operations 

05 Jan 2026

US$ 20.00

BGH Capital (BGH) is to acquire the Asia-Pacific operations of South Africa-headquartered specialty pharmaceutical...

Price / article: US$20.00
OR existing subscriber
Related Publications

Dalton Venture has led the latest financing round of Guangzhou Yuandong Biotechnology Co Ltd, a bio-manufacturing ......

The holding companies of Cheap as Chips, which is backed by Alceon Private Equity, have filed for voluntary...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.